Subscribe free

HPB & Spleen ·

Tumor burden score improves survival prediction in liver cancer.

A new classification for hepatocellular carcinoma enhances predictive accuracy for overall survival. In a study involving 1,766 patients, incorporating the tumor burden score (TBS) allowed reclassification into distinct categories, revealing improved five-year survival rates: the TBS-br model yielded rates of 70.8%, 58.3%, and 40.0% compared to the original boundary category’s 65.1%, 48.2%, and 46.4%. This research offers an advanced tool for clinicians assessing surgical candidacy in liver cancer patients.

Journal Article by Akabane M, Kawashima J (…) Pawlik TM et 21 al. in Ann Surg Open

Copyright © 2025 The Author(s). Published by Wolters Kluwer Health, Inc.

read the whole article in Ann Surg Open

open it in PubMed

Summaries are written to help you decide what to read. They do not replace the full paper.

Free · 5 minutes a day

Get every new paper in HPB & Spleen.

Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.

Specialty newsletters: every new paper in your field, as a list of titles linked to the source. Daily Selection: the five that matter, cut to their key points.

FreeNo spamOne-click unsubscribe

More in HPB & Spleen

The latest stitches

Surg Endosc6 Nov 2026

A new cut for robotic liver surgery

A close-to-open cutting method was used for robotic liver resection, with no bile leaks and shorter hospital stays than after laparoscopy.

Surg Endosc6 Nov 2026

Robotic bile duct stone surgery: fewer complications

Removing large common bile duct stones with a robot rather than laparoscopically was linked to fewer complications and shorter hospital stays, at a higher cost, in a study from one Chinese hospital.

All papers in HPB & Spleen →